Monthly Archives: July 2025

The following price concessions granted in June 2025 have rolled over to July 2025: Drug Pack size June 2025 price concession Co-amoxiclav 250mg/62mg/5ml oral suspension 100 £5.06 Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £4.79 Fenofibrate micronised 160mg tablets 28 £3.60 Nizatidine 150mg capsules 30 £21.69 Sulfasalazine 500mg tablets 112 £6.61 Please note any rolled [...]

The post Rolled over price concessions for July 2025 appeared first on Community Pharmacy England.

NHS England has announced that the rollout of the Electronic Prescription Service (EPS) is well underway across primary care in Wales. As of June 2025: All seven pharmacy system suppliers operating in Wales now support EPS. The majority of pharmacies in Wales are now able to receive electronic prescriptions. EPS utilisation is estimated to be [...]

The post EPS rolls out across Wales appeared first on Community Pharmacy England.

Why Participate? Pharmacy teams taking part in the pilot will receive a structured support package and help shape a future model for sector-wide cybersecurity support. Key benefits include: Boosting staff confidence in identifying, responding to, and reporting cyber incidents Raising awareness of common cyber threats and their impact on pharmacy operations Access to free digital [...]

The post Reminder: Volunteer to join the pharmacy cybersecurity support pilot appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (01/07/2025) confirmed the following final list of price concessions for June 2025.  Drug Pack size Price concession Ascorbic acid 100mg tablets 28 £26.89 Co-amoxiclav 250mg/62mg/5ml oral suspension 100 £5.06 Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £4.79 Fenofibrate micronised 160mg tablets 28 £3.60 Mercaptopurine 50mg tablets [...]

The post June 2025 Price Concessions Final Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets (Erythrocin 250 Tablets) Amdipharm UK Ltd Drug alert number: EL(25)A/32 Date issued: 01 July 2025 Amdipharm UK Ltd has informed MHRA that the Patient information leaflet (PIL) in the cartons for the batch listed in this notification includes a superseded PIL. The superseded PIL used [...]

The post Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd appeared first on Community Pharmacy England.